Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Takeaway: This approval cements Novo Nordisks leadership in cardiometabolic innovation, extending GLP-1based CV protection to a wider population and setting a new benchmark in diabetes and heart health management
37% More Weight Loss with Noom Habits More Weight Loss with Noom Habits Building healthy habits with Noom may help you lose 37% more weight while on a GLP-1.** **Based on a January 2026 analysis of 14,203 Noom GLP-1Rx Program members who actively logged their weight over a 40-week period
What neither drug replaces Neither Mounjaro nor Ozempic replaces the foundations of care
PlexusDx compounded semaglutide ($189/mo) paired with optional genetic testing offers a precision-first alternative for patients seeking personalized, biomarker-informed GLP-1 therapy
US$ 27.66
US$ 25.82
US$ 23.27
